Skandinaviska Enskilda Banken (SEB)’s Pacific Biosciences PACB Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-42,400	Closed	-$416K	–	908
2023 Q4	$416K	Sell	42,400 -22,800	-35%	-$186K	﹤0.01%	790
2023 Q3	$544K	Sell	65,200 -13,400	-17%	-$153K	﹤0.01%	754
2023 Q2	$1.04M	Buy	78,600 +25,500	+48%	+$310K	0.01%	690
2023 Q1	$615K	Buy	+53,100	New	+$528K	﹤0.01%	752
2022 Q1	–	Sell	-24,505	Closed	-$512K	–	1046
2021 Q4	$512K	Hold	24,505	–	–	﹤0.01%	843
2021 Q3	$626K	Hold	24,505	–	–	﹤0.01%	847
2021 Q2	$857K	Buy	+24,505	New	+$713K	0.01%	829

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s PACB Position: Q1 2024 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Pacific Biosciences (PACB) in Q1 2024, closing a stake of 42,400 shares — an estimated $416K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in PACB in Q2 2021 and held it in 7 quarters. The position peaked at $1.04M in Q2 2023. 268 funds tracked by Wall St. Rank hold PACB as of Q1 2024.

Skandinaviska Enskilda Banken (SEB) reported no remaining Pacific Biosciences position as of Q1 2024 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 42,400 Pacific Biosciences shares in Q1 2024, an estimated $416K.
Skandinaviska Enskilda Banken (SEB) first reported a position in Pacific Biosciences in Q2 2021 and held it in 7 quarters.
Skandinaviska Enskilda Banken (SEB)'s Pacific Biosciences position peaked at $1.04M in Q2 2023.
268 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2024.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2024, filed 13 May 2024.